Cardiawave confirms the safety of Valvosoft®, its non-invasive ultrasound treatment for aortic stenosis.June 14, 2022Press Release
Cardiawave announces the authorization by the French National Agency for the Safety of Medicines and Health Products (ANSM) to proceed with a new clinical study in France.May 2, 2022Press Release
Cardiawave announces the success of its clinical trial to treat aortic stenosis.March 22, 2022Press Release
